These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7656749)

  • 1. B72.3 immunoreactivity in benign abdominal lymph nodes associated with gastrointestinal disease.
    Loy TS; Haege DD
    Dis Colon Rectum; 1995 Sep; 38(9):983-7. PubMed ID: 7656749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative detection of occult colon cancer micrometastases using 125 I-radiolabled monoclonal antibody CC49.
    Cote RJ; Houchens DP; Hitchcock CL; Saad AD; Nines RG; Greenson JK; Schneebaum S; Arnold MW; Martin EW
    Cancer; 1996 Feb; 77(4):613-20. PubMed ID: 8616751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.
    Roselli M; Hitchcock CL; Molinolo A; Milenic DE; Colcher D; Martin EW; Hinkle GH; Schlom J
    Anticancer Res; 1995; 15(3):975-84. PubMed ID: 7645989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAG-72 expression in lymph nodes and RIGS.
    Hitchcock CL; Arnold MW; Young DC; Schneebaum S; Martin EW
    Dis Colon Rectum; 1996 Apr; 39(4):473-5. PubMed ID: 8878513
    [No Abstract]   [Full Text] [Related]  

  • 5. Reactivity of B72.3 with adenocarcinomas. An immunohistochemical study of 476 cases.
    Loy TS; Nashelsky MB
    Cancer; 1993 Oct; 72(8):2495-8. PubMed ID: 8402466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic heterogeneity of a tumor-associated antigen in adenocarcinomas of the colon and their metastases as demonstrated by monoclonal antibody B72.3.
    Lottich SC; Szpak CA; Johnston WW; Thor A; Schlom J
    Cancer Invest; 1986; 4(5):387-95. PubMed ID: 2433005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival.
    Greenson JK; Isenhart CE; Rice R; Mojzisik C; Houchens D; Martin EW
    Cancer; 1994 Feb; 73(3):563-9. PubMed ID: 7507795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical evaluation of canine carcinomas with monoclonal antibody B72.3.
    Clemo FA; DeNicola DB; Delaney LJ
    Vet Pathol; 1993 Mar; 30(2):140-5. PubMed ID: 8470336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor associated glycoprotein-72 is highly expressed in prostatic adenocarcinomas.
    Myers RB; Meredith RF; Schlom J; LoBuglio AF; Bueschen AJ; Wheeler RH; Stockard CR; Grizzle WE
    J Urol; 1994 Jul; 152(1):243-6. PubMed ID: 8201675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of radioimmunoguided surgery using iodine-125-labeled B72.3 monoclonal antibody in gastric cancer surgery.
    Lucisano E; Bertoglio S
    Semin Surg Oncol; 1998 Dec; 15(4):212-4. PubMed ID: 9829373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical evidence of immune responses to tumor-associated antigens in lymph nodes of colon carcinoma patients.
    Mariani-Costantini R; Muraro R; Ficari F; Valli C; Bei R; Tonelli F; Caramia F; Frati L
    Cancer; 1991 Jun; 67(11):2880-6. PubMed ID: 1709062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
    Molinolo A; Simpson JF; Thor A; Schlom J
    Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.
    Johnston WW; Szpak CA; Thor A; Schlom J
    Cancer Res; 1986 Dec; 46(12 Pt 1):6462-70. PubMed ID: 3022920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tumor-associated antigen in carcinoma of the pancreas defined by monoclonal antibody B72.3.
    Lyubsky S; Madariaga J; Lozowski M; Mishriki Y; Schuss A; Chao S; Lundy J
    Am J Clin Pathol; 1988 Feb; 89(2):160-7. PubMed ID: 3277379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactivity of canine epithelial and nonepithelial neoplasms with monoclonal antibody B72.3.
    Clemo FA; DeNicola DB; Morrison WB; Carlton WW
    Vet Pathol; 1995 Mar; 32(2):147-54. PubMed ID: 7771055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoscintigraphy of human colorectal carcinoma metastases in athymic mice by use of radioiodinated B72.3 monoclonal antibody.
    Shah SA; Gallagher BM; Sands H
    J Natl Cancer Inst; 1987 Jun; 78(6):1069-77. PubMed ID: 3473248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast carcinoma detection with a combination of radiolabeled monoclonal antibodies. Promising results from immunohistochemistry studies.
    Mangili F; Sassi I; Di Rocco M; Leone BE; Garancini P; Santambrogio G
    Cancer; 1996 Dec; 78(11):2334-9. PubMed ID: 8941003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity of CO17-1A and B72.3 in benign and malignant pancreatic diseases.
    Takiyama Y; Tempero MA; Takasaki H; Onda M; Tsuchiya R; Büchler M; Ness M; Colcher D; Schlom J; Pour PM
    Hum Pathol; 1989 Sep; 20(9):832-8. PubMed ID: 2673979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
    Johnston WW
    Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoguided surgery.
    Veroux G; Nicosia AS; Veroux P; Cardillo P; Veroux M; Amodeo C
    Hepatogastroenterology; 1999; 46(30):3099-108. PubMed ID: 10626169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.